Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.17 | 12.8787878788 | 1.32 | 1.49 | 1.2 | 203273 | 1.31793006 | CS |
4 | 0.19 | 14.6153846154 | 1.3 | 1.5 | 1.111 | 241799 | 1.34060884 | CS |
12 | 0.48 | 47.5247524752 | 1.01 | 1.75 | 0.92 | 332107 | 1.23268765 | CS |
26 | 0.8303 | 125.860239503 | 0.6597 | 1.9891 | 0.45 | 536935 | 1.23016466 | CS |
52 | -0.76 | -33.7777777778 | 2.25 | 2.37 | 0.45 | 442320 | 1.30730017 | CS |
156 | -5.2 | -77.7279521674 | 6.69 | 7.455 | 0.45 | 352335 | 2.6404173 | CS |
260 | -17.28 | -92.0618007459 | 18.77 | 35.5 | 0.45 | 340210 | 7.46046022 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions